BioCryst Pharmaceuticals Statistics
NASDAQ: BCRXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
7.22-0.10 (-1.37%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
BioCryst Pharmaceuticals by the numbers
BioCryst Pharmaceuticals has a market capitalization of $1.86 billion based on 257.30M shares outstanding. With trailing EPS of $-1.28, BioCryst Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 10.7% below its 50-day average and 18.2% below its 200-day average.
Average daily trading volume is 4.97M shares, or about $35.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BCRX valuation vs. peer median
| Metric | BCRX | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.86B | $1.72B | +8% |
| Avg. volume | 4.97M | 1.59M | +213% |
Peer median across 8 companies: COAG, REPL, LYCA, MAZE, BEAM, VIR, RXRX, ALVO.
Valuation
- Market cap
- $1.86B
- Forward P/E
- 8.44
- Price / sales (latest FY)
- 2.12
- EPS (TTM)
- $-1.28
- Shares outstanding
- 257.30M
Price and trading
- Previous close
- 7.32
- Open
- 7.26
- Day range
- 7.15 – 7.39
- 52-week range
- 6.23 – 11.22
- 52-week change
- +3.59%
- Beta
- —
- Volume
- 3.85M
- Average volume
- 4.97M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 1.86B
- Forward Pe
- 8.44
- Eps
- -1.28
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 11.22
- Week52 Low
- 6.23
- Avg Volume
- 4.97M
- Shares Outstanding
- 257.30M
- Ma50
- 8.08
- Ma200
- 8.82
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -35.65%
- Pct From52w Low
- 15.89%